3D DOSE ESCALATION FOR PROSTATE CANCER

前列腺癌的 3D 剂量递增

• 批准号: 2100976
• 负责人: Theodore Phillips
• 金额: $ 7.04万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 1993
• 资助国家: 美国
• 起止时间: 1993-06-01 至 1997-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2100976
• 关键词: 3D; DOSE; ESCALATION; PROSTATE; CANCER

项目成果

Pretreatment prostate-specific antigen and Gleason score predict the risk of extracapsular extension and the risk of failure following radiotherapy in patients with clinically localized prostate cancer.

治疗前前列腺特异性抗原和格里森评分可预测临床局限性前列腺癌患者的囊外扩散风险和放疗失败风险。

• 发表时间: 2000
• 期刊: Seminars in urologic oncology
• 作者: Roach3rd,M;Chen,A;Song,J;Diaz,A;PrestiJr,J;Carroll,P
• 通讯作者: Carroll,P

Bilateral arcs using "averaged beam's eye views": a simplified technique for delivering 3-D based conformal radiotherapy.

使用“平均射束视野”的双边弧：一种用于提供基于 3D 适形放射治疗的简化技术。

• DOI: 10.1016/0958-3947(94)90050-7
• 发表时间: 1994
• 期刊: Medical dosimetry : official journal of the American Association of Medical Dosimetrists
• 作者: Roach3rd,M;Akazawa,PF;Pickett,B;Purser,P;Parkinson,D;Meyler,TS;Margolis,LW
• 通讯作者: Margolis,LW

Identification of a high-risk clinically localized prostate cancer subgroup receiving maximum benefit from whole-pelvic irradiation.

确定从全盆腔照射中获得最大益处的高风险临床局部前列腺癌亚组。

• 发表时间: 1998
• 期刊: The cancer journal from Scientific American.
• 作者: Seaward,SA;Weinberg,V;Lewis,P;Leigh,B;Phillips,TL;Roach3rd,M
• 通讯作者: Roach3rd,M